AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1638578
Drug: Gentamicin-Clindamycin (G/C)
RxNorm normalized name: clindamycin Topical Solution [C/T/S]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin-Clindamycin (G/C)
Trial: 6707245
Drug: Thioridazine plus
RxNorm normalized name: Thioridazine
DrugBank: Thioridazine (DB00679)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thioridazine plus either social skills training or holistic health therapy
Trial: 30853647
Drug: Purgative Manna
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purgative Manna drops (5 drops/kg divided into three doses per day for three days)
Trial: 29903598
Drug: Cognitive functional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive functional therapy
Trial: 29903598
Drug: Combined manual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined manual therapy and motor control exercises
Trial: 26628861
Drug: Gratisovir (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gratisovir (400 mg daily)
Trial: 26628861
Drug: Grateziano (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grateziano (400 mg daily)
Trial: 24627237
Drug: Docetaxel 45
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 45 mg/m² with bolus and 44 h infusion of 5-Fu/Lv (arm T)
Trial: 24627237
Drug: Irinotecan 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan 180 mg/m² with bolus and 44 h infusion of 5-Fu/Lv (arm C)
Trial: 24627237
Drug: Chemotherapy in
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy in advanced GC
Trial: 6192505
Drug: Tendamistate 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tendamistate 100 mg
Trial: 6192505
Drug: Tendamistate 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tendamistate 200 mg
Trial: 31649125
Drug: Intravenous microtracer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous microtracer of 10 µg [14C]nemiralisib
Trial: 31649125
Drug: Inhaled nonradiolabeled
RxNorm normalized name: Radiolabelled DUNP19
DrugBank: RAD 502 (DB17328)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nonradiolabeled 1000 µg dose
Trial: 31649125
Drug: Oral 800
RxNorm normalized name: ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral 800 µg dose of [14C]nemiralisib
Trial: 25395210
Drug: NSC 631570
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSC 631570 administered i.v. in a single therapeutic dose
Trial: 25395210
Drug: NSC 631570
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSC 631570 administered i.v. in an outpatient setting
Trial: 25395210
Drug: NSC 631570
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSC 631570 administered in an inpatient setting
Trial: 25395210
Drug: Active participants
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active participants after drug injection
Trial: 24421054
Drug: β‐glucan 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β‐glucan 10 mg capsules administered twice a day for 10 days
Trial: 19144772
Drug: CRA13 1-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRA13 1-80 mg
Trial: 19144772
Drug: CRA13 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRA13 40 mg with food
Trial: 19144772
Drug: CRA13 40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRA13 40-80 mg
Trial: 12642692
Drug: Thalidomide monotherapy
RxNorm normalized name: Thalidomide
DrugBank: Thalidomide (DB01041)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Thalidomide monotherapy (200 to 1,200 mg/day)
Trial: 9457020
Drug: Headgear (combination)
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Headgear (combination)
Trial: 15879435
Drug: Budesonide (inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (inhaled corticosteroid)
Trial: 10172461
Drug: Budesonide (once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (once-daily administration in dry powder form via Turbuhaler)
Trial: 1761121
Drug: Heparin (low-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (low-dose continuous administration)
Trial: 10365742
Drug: No Heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Heparin
Trial: 6813959
Drug: Trimipramine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimipramine (25 mg, two tablets)
Trial: 30756339
Drug: Iloprost inhalation
RxNorm normalized name: Iloprost Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iloprost inhalation (20 µg)
Trial: 22166801
Drug: Total iron
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total iron (diet and supplements)
Trial: 22166801
Drug: Iron from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron from supplements
Trial: 17721018
Drug: hANP administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: hANP administration
Trial: 15206993
Drug: Grapefruit juice
RxNorm normalized name: grapefruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grapefruit juice 200 ml
Trial: 12375798
Drug: Topoisomerase I
RxNorm normalized name: Topoisomerase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topoisomerase I inhibitors in nonplatinum combinations
Trial: 9661000
Drug: Pefloxacin 800
RxNorm normalized name: pefloxacin
DrugBank: Pefloxacin (DB00487)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pefloxacin 800 mg
Trial: 8619366
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) 0.05 IU/kg/day
Trial: 8619366
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) 0.10 IU/kg/day
Trial: 8619366
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) 0.20 IU/kg/day
Trial: 344042
Drug: Bromocryptine (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocryptine (average daily dose 71 mg)
Trial: 26387012
Drug: Hypothermia treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothermia treatment for neonatal encephalopathy
Trial: 9142061
Drug: Monovalent live
RxNorm normalized name: INFLUENZA A (H1N1) MONOVALENT LIVE VACCINE,NASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent live attenuated (RA27/3 strain) rubella vaccine
Trial: 24256334
Drug: Lemon candy
RxNorm normalized name: LEMON
DrugBank: Lemon (DB10538)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lemon candy (standard treatment)
Trial: 23919857
Drug: E2V/DNG (oestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2V/DNG (oestradiol valerate/dienogest) administered in a dynamic dosing regimen (26/2 regimen)
Trial: 16263828
Drug: 0.24 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.24 mg/kg x wk GH
Trial: 16263828
Drug: 0.37 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.37 mg/kg x wk GH
Trial: 12748212
Drug: Pharmacist led
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist led intervention to improve drug compliance
Trial: 12748212
Drug: Model with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Model with addition of beta blockers
Trial: 8820427
Drug: Metoprolol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (200 mg) + Quinidine (100 mg daily)
Trial: 3893701
Drug: Ibuprofen-codeine phosphate
RxNorm normalized name: codeine / ibuprofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen-codeine phosphate combination
Trial: 27559840
Drug: Adapted-dose (AD)
RxNorm normalized name: ADAPT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adapted-dose (AD) group: increase of ribavirin dose if D0AUC0‐4h <1755 mcg·h·L
Trial: 27559840
Drug: Fixed-dose (FD)
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose (FD) group: standard of care with peginterferon‐α2a 180 mcg·wk and weight‐based ribavirin 1000‐1200 mg/d during 48 weeks
Trial: 27559840
Drug: Adapted-dose (AD)
RxNorm normalized name: ADAPT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adapted-dose (AD) group
Trial: 27559840
Drug: Fixed-dose (FD)
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose (FD) group
Trial: 22909077
Drug: Antibiotic/steroid-coated sutures
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic/steroid-coated sutures (200 cases)
Trial: 22909077
Drug: Antiseptic-soaked and
RxNorm normalized name: Listerine Antiseptic
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiseptic-soaked and antibiotic/steroid-coated sutures (141 cases)
Trial: 9914571
Drug: Danazol 200
RxNorm normalized name: danazol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol 200 mg daily during the luteal phase
Trial: 2102130
Drug: Ketanserin (40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (40-80 mg/day, oral therapy)
Trial: 2102130
Drug: Ketanserin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (20 mg, sublingual; 10 mg, intravenous)
Trial: 30579447
Drug: Low-fidelity simulation
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fidelity simulation training with tablet-paired physical endovascular tool navigation (group S)
Trial: 30579447
Drug: Low-fidelity simulation
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fidelity simulation training with tablet-paired touch-gesture navigation (group A)
Trial: 21733417
Drug: Diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 75 mg orally twice per day for 10 days
Trial: 21733417
Drug: Paracetamol 500
RxNorm normalized name: Paracetamol 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 500 mg orally three times per day for 10 days
Trial: 7982769
Drug: Oral theophylline
RxNorm normalized name: theophylline Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral theophylline (levels 9.5 +/- 1 mg/l)
Trial: 31990581
Drug: Collagen peptide
RxNorm normalized name: Procollagen peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen peptide (CP) supplementation (10 g/day for 12 weeks)
Trial: 28123764
Drug: Anthracycline chemotherapy
RxNorm normalized name: methacycline
DrugBank: Metacycline (DB00931)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anthracycline chemotherapy
Trial: 16777690
Drug: Irinotecan (130
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan (130 mg/m2 IV over 90 minutes) and Docetaxel (50 mg/m2 IV over 60 minutes) on Day 1 q3 weeks for 6 cycles
Trial: 15577128
Drug: Raloxifene at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene at a dosage of 60 or 120 mg/day for 3 years
Trial: 10989959
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg 17beta-estradiol valerate (E2)
Trial: 31421989
Drug: HDM SLIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HDM SLIT tablets for 4 weeks followed by dual therapy with JCP SLIT tablets for 8 weeks
Trial: 31421989
Drug: JCP SLIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JCP SLIT tablets for 4 weeks followed by dual therapy with HDM SLIT tablets for 8 weeks
Trial: 31421989
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy with both SLIT tablets administered within 5 min after 4 weeks of monotherapy
Trial: 28330808
Drug: Sunitinib (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunitinib (continuous daily dosing schedule)
Trial: 23357837
Drug: 100-mg pregabalin
RxNorm normalized name: pregabalin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100-mg pregabalin capsule
Trial: 23357837
Drug: 100-mg pregabalin
RxNorm normalized name: pregabalin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100-mg pregabalin solution (capsule dissolved in water)
Trial: 21192149
Drug: Rimonabant (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimonabant (20 mg/d)
Trial: 18629368
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination strategy (perindopril/indapamide 2 mg/0.625 mg, with possible increase to 3 mg/0.935 mg, and 4 mg/1.250 mg if needed)
Trial: 18629368
Drug: Sequential monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential monotherapy approach (atenolol 50 mg, followed by losartan 50 mg and amlodipine 5 mg if needed)
Trial: 18629368
Drug: Stepped-care strategy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepped-care strategy (valsartan 40 mg, followed by valsartan 80 mg and valsartan 80 mg + hydrochlorothiazide 12.5 mg if needed)
Trial: 16613215
Drug: Lipid-lowering therapy
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-lowering therapy (including probucol and pravastatin)
Trial: 12621389
Drug: Telithromycin (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telithromycin (800 mg daily, repeated doses)
Trial: 12621389
Drug: Telithromycin (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telithromycin (800 mg, single dose)
Trial: 12621389
Drug: Telithromycin (1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telithromycin (1600 mg, single dose)
Trial: 12621389
Drug: Telithromycin (2400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telithromycin (2400 mg, single dose)
Trial: 6890700
Drug: Switch from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switch from placebo to active medication
Trial: 30764769
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment for 7 days
Trial: 30764769
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment for 14 days
Trial: 26983390
Drug: UC-MSC treatment
RxNorm normalized name: Astri-UC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UC-MSC treatment (0.5-1.0×10(6) cells/kg/month for 3 months)
Trial: 26983390
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical treatment only (control group)
Trial: 23277248
Drug: Methylphenidate (30
RxNorm normalized name: methylphenidate (30/70 release) 10 mg/24 hr oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (30 mg)
Trial: 11008278
Drug: Balneophysical treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balneophysical treatments (process expectation)
Trial: 28285432
Drug: Bovine colostrum
RxNorm normalized name: Bovine Colostrum
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine colostrum (BC) 3.2 g/day
Trial: 28285432
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein (WP) 3.2 g/day
Trial: 19065892
Drug: PTS plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTS plus Aspirin
Trial: 19065892
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group D (no aspirin)
Trial: 12477757
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg twice daily + Amoxicillin 1 g twice daily
Trial: 8829556
Drug: Indomethacin 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 0.4 mg/kg bolus followed by continuous infusion 0.4 mg/kg/h
Trial: 8829556
Drug: Indomethacin 0.1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 0.1, 0.2, and 0.3 mg/kg bolus followed by continuous infusion of 0.1, 0.2, and 0.3 mg/kg/h
Trial: 9229881
Drug: Rectal application
RxNorm normalized name: Rectal Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal application of 100 mg indomethacin
Trial: 29053981
Drug: Dim Red
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dim Red Light Therapy (dRLT)
Trial: 15923802
Drug: Single high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single high-dose chemotherapy (S)
Trial: 6480458
Drug: Ro-03-8799 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ro-03-8799 at 1 g/m2
Trial: 29771017
Drug: Intranasal corticosteroids
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal corticosteroids combined with normal saline nasal irrigation
Trial: 29771017
Drug: Intranasal corticosteroids
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal corticosteroids only
Trial: 29771017
Drug: Intranasal corticosteroids
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal corticosteroids combined with antihistamines
Trial: 24727364
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT-AN)
Trial: 19773728
Drug: Transurethral Microwave
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transurethral Microwave Therapy (TUMT)
Trial: 19773728
Drug: Holmium Laser
RxNorm normalized name: holmium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Holmium Laser Therapy
Trial: 18991132
Drug: Conduct disorder
RxNorm normalized name: Cystic fibrosis transmembrane conductance regulator
DrugBank: Cystic fibrosis transmembrane conductance regulator (DB15180)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conduct disorder in youth with high levels of hyperactivity symptoms, poor school functioning, and peer alcohol and drug use
Trial: 12608319
Drug: Photodynamic Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic Therapy (PDT) with verteporfin
Trial: 10666802
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil 30 mg/kg/day for 14 days
Trial: 2216203
Drug: Weekly membrane
RxNorm normalized name: Weekly Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly membrane stripping beginning at 38 weeks
Trial: 202160
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (400 mg/day)
Trial: 9683924
Drug: Angiotensin I
RxNorm normalized name: ANGIOTENSIN I
DrugBank: Angiotensin 1-7 (DB11720)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin I (AngI) infusion at doses of 0.3, 1, and 3 pmol x kg‐1 x min‐1
Trial: 9683924
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II (AngII) infusion at doses of 0.3, 1, and 3 pmol x kg‐1 x min‐1
Trial: 7706607
Drug: Logistic regression
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Logistic regression model including serum albumin, body mass index, renal disease, Katz Index of Activities of Daily Living score, weight loss
Trial: 2785775
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with dog dander and hair extract (n = 35)
Trial: 2785775
Drug: Maintenance treatment
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance treatment (n = 15)
Trial: 11856774
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (n = 12)
Trial: 27836809
Drug: Hecolin vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hecolin vaccine (1 to 3 doses)
Trial: 26515417
Drug: no antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no antiplatelet medication (controls)
Trial: 19454355
Drug: Sibutramine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine (10 mg daily) with lifestyle change
Trial: 16458640
Drug: 400 microg
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg buccal misoprostol
Trial: 15298564
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g fish oil capsules (containing 3.7 g n‐3 PUFA)
Trial: 15298564
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g olive oil capsules
Trial: 8656678
Drug: Low-dose all-trans
RxNorm normalized name: all-trans-retinol
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose all-trans retinoic acid (ATRA) at 15-20 mg/m2/day
Trial: 8656678
Drug: Low-dose all-trans
RxNorm normalized name: all-trans-retinol
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose all-trans retinoic acid (ATRA)
Trial: 8656678
Drug: High-dose all-trans
RxNorm normalized name: all-trans-retinol
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose all-trans retinoic acid (ATRA)
Trial: 6807435
Drug: Sulpiride 50
RxNorm normalized name: sulpiride 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulpiride 50 mg thrice daily for four weeks